References
- Rose B. D. Renal disease in rheumatoid arthritis. UpToDate 2007; 15.1
- Samuels B., Lee J. C., Engleman E. P., Hopper J. Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy. Medicine 1978; 57: 319–27
- Zarza L. P., Sanchez E. N., Acin P. A., Ara J. M., Banos J. G. Membranous glomerulonephritis in rheumatoid arthritis unrelated to gold, d‐penicillamine or other connective tissue disease. Clin Rheumatol 1996; 15: 385–8
- Falk R. J., Jennette J. C., Nachman P. H. Primary glomerular disease. Brenner and Rector's The Kidney, B. M Brenner. Saunders, Philadelphia 2004, 7th edn
- Remuzzi G., Chiurchiu C., Abbate M., Brusegan V., Bontempelli, Ruggenenti P. Rituximab for idiopathic membranous nephropathy. Lancet 2002; 360: 923–4
- Rituxan full prescribing information, Genentech, Inc. 2006
- Nydegger U. E. Immune complexes. Kelley's Textbook of Rheumatology, E. D Harris, R. C Budd, M. C Genovese, G. S Firestein, J. S Sargent, C. B Sledge. Elsevier Saunders, Philadelphia 2005, 7th edn
- Firestein G. S. Etiology and pathogenesis of rheumatoid arthritis. Kelley's Textbook of Rheumatology, E. D Harris, R. C Budd, M. C Genovese, G. S Firestein, J. S Sargent, C. B Sledge. Elsevier Saunders, Philadelphia 2005, 7th edn
- Edwards J. C. W., Szczepanski L., Szechinski J., Filipowicz‐Sosnowska A., Emery P., Close D. R., et al. Efficacy of B‐cell‐targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572–81
- Cohen S. B., Emery P., Greenwald M. W., Dougados M., Furie R. A., Genovese M. C., et al. Rituximab for rheumatoid arthritis refractory to anti‐tumor necrosis factor inhibitors. Arthritis Rheum 2006; 54: 2793–806